Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer

"The book is well written and the topics of individual chapters are wisely chosen in order to cover the most important aspects of targeted radionuclide therapy. This book gives rich insights into theoretical and practical aspects of targeted radionuclide therapy, particularly considering its position as a rapidly emerging, exciting, new therapy modality for cancer. It speaks in favor of this book that valuable information is available for people entering the field, as well as for experienced researchers who need profound information." (ChemMedChem, November 2010)

"This excellent book covers the whole field of targeted radionuclide therapy. The book includes choice of targeting agents and radionuclides, radiochemistry and radiolabeling, dosimetry, good coverage of medical aspects on selected tumor types (e.g. CNS tumors, neuroendocrine tumors, lymphomas and leukemias) and some aspects on relevant biological processes. Internationally well-recognized scientists have written the chapters. The book is unique thanks to chapters on viral introduction of receptors for radionuclide targeting, suitable tumor models, economy of targeted radionuclide therapy and regulatory matters. One aspect that strongly speaks in favor for this book is that targeted radionuclide therapy is an interesting and probably in many cases necessary complement or alternative to chemotherapy, especially when the cancer cells have gained multidrug resistance.... The book is suitable for PhD students in the field, for medical doctors in nuclear medicine and for all persons in the medical field that looks for new avenues to more effective killing of cancer cells.... [It] is an excellent written and up-to date introduction to the field of targeted radionuclide therapy of cancer and the book is strongly recommended to interested readers."
—Dr. Jörgen Carlsson, Biomedical Radiation Sciences, Uppsala University